Aandelen in “Fabricage van farmaceutische preparaten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
I-Mab |
14/11 | 1,070 USD
+2,88% |
+2,88% |
|
iBio Inc |
14/11 | 2,150 USD
-7,33% |
-7,33% |
|
IGM Biosciences Inc |
14/11 | 10,100 USD
-9,42% |
-9,42% |
|
Immucell Corp. |
14/11 | 3,600 USD
+1,98% |
+1,98% |
|
Immunic Inc |
14/11 | 1,090 USD
-6,84% |
-6,84% |
|
Immuron Limited |
14/11 | 1,930 USD
-2,53% |
-2,53% |
|
InflaRx NV |
14/11 | 2,030 USD
+18,71% |
+18,71% |
|
InMed Pharmaceuticals Inc |
14/11 | 5,080 USD
+2.089,66% |
+2.089,66% |
Innate Pharma |
14/11 | 1,524 EUR
-5,34% |
-5,34% |
|
Innate Pharma |
14/11 | 1,665 USD
-0,66% |
-0,66% |
|
Innoviva Inc |
14/11 | 19,240 USD
-4,28% |
-4,28% |
|
Inozyme Pharma Inc |
14/11 | 3,430 USD
-3,38% |
-3,38% |
|
Insmed Inc |
14/11 | 71,260 USD
+0,93% |
+0,93% |
|
Intellia Therapeutics Inc |
14/11 | 15,120 USD
-6,15% |
-6,15% |
|
Intra-Cellular Therapies Inc |
14/11 | 87,630 USD
-0,67% |
-0,67% |
|
Ionis Pharmaceuticals Inc |
14/11 | 37,230 USD
-1,46% |
-1,46% |
|
Ironwood Pharmaceuticals Inc |
14/11 | 4,110 USD
-4,64% |
-4,64% |
|
Iterum Therapeutics Plc |
14/11 | 1,360 USD
-4,90% |
-4,90% |